Table 1.
Patients' characteristics
| Parameters | Test drug and study site | |||||
|---|---|---|---|---|---|---|
| Chloroquine (CQ) | Artemether-lumefantrine (AL) | |||||
| Debrezeit | Nazareth | Total | Debrezeit | Nazareth | Total | |
| Total enrolled | 27 | 44 | 71 | 36 | 52 | 88 |
| Gender | ||||||
| Male | 15 (55.6%) | 19 (43.2%) | 34 (47.9%) | 18 (50.0%) | 21 (40.4%) | 39 (44.3%) |
| Female | 12 (44.4%) | 25 (56.8%) | 37 (52.1%) | 18 (50.0%) | 31 (59.6%) | 49 (55.7%) |
| Age group | ||||||
| Under 5 years | 0 | 5 (11.4%) | 5 (7.0%) | 2 (5.6%) | 7 (13.5%) | 9 (10.2%) |
| 5 years and above | 27 (100%) | 39 (88.6%) | 66 (93%) | 34 (94.4%) | 45 (86.5%) | 79 (89.8%) |
| Median age in years (interquartile range) | 21 (9.5–30) | 17.5 (13–25) | 19 (10–26) | 17 (10–25) | 17 (7.6–23.3) | 17 (9.5–24) |
| Mean weight ± SD (range; kg) | 42.8 ± 17.2 | 45.0 ± 16.9 | 44.1 ± 16.7 | 42.5 ± 17.1 | 41.7 ± 19.1 | 42.0 ± 18.7 |